We're in beta. Stay tuned for updates.x
Loading...
PODCAST

On The Pen With Dave Knapp

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

All Episodes

00:45:44
GLP-1 State of the Union
en-us
00:45:58
Lower Cost Zepbound and Wegovy? TrumpRX Announcement...
en-us
00:23:55
Eli Lilly Earnings Call Recap: NEW GLP-1 GIP Peptide...
en-us
00:29:41
Retatrutide + Tirzepatide Grey Market Clampdown + 1...
en-us
00:49:48
HLTH 2025: Obesity Care Superstar Interviews
en-us
00:29:33
TRUMP: Ozempic Will Soon be $150 in the US! Meet the...
en-us
00:27:44
Wegovy and Ozempic Users: FDA's Scathing Report on...
en-us
00:40:26
Retatrutide News That Could Change Everything for...
en-us
00:38:01
Sobriety Meets Weight Loss: The Ethan Suplee Interview
en-us
01:10:55
Mounjaro Hair Loss + NFL Lineman Discovers Power in...
en-us
00:42:24
Stopping Zepbound and Maintaining with Revita
en-us
01:17:07
GLP-1 Treatment and Advocacy with Dr. Leslie Golden
en-us
00:34:13
Pfizer GLP-1 Play Worth $7.3B + Compound Tirzepatide...
en-us
00:50:03
GLP-1 Weight Loss, Why It's About So Much More for...
en-us
00:44:20
Compound GLP-1 Legislation + FDA Warning Letter to HIMS
en-us
00:39:02
FDA CRACKDOWN on Compounded GLP-1s | Novo’s Gut Hack...
en-us
00:26:01
Is Wegovy Better Than Zepbound? Plus the First...
en-us
01:06:26
Zepbound Compound Lawsuit Update: Eli Lilly Vs Mochi
en-us
00:36:00
Eli Lilly VS Mochi Update + Big Lilly Orforglipron...
en-us
00:34:01
Ozempic Price Cut + New Obesity Pill Data
en-us
156 results

Similar Podcasts